Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies
NCT03762512 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-06-22
Summary
Placenta will be collected and from these, mitochondrial will be harvested. Mitochondria will be used in mitochondrial augmentation therapy.
Conditions
- Pregnancy Related
Sponsors & Collaborators
-
Minovia Therapeutics Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2027-12-31
- Completion
- 2028-03-31
Countries
- Israel
Study Locations
More Related Trials
-
Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19
NCT04366271 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium
NCT03724617 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia
NCT01472289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
NCT07332338 ·Status: AVAILABLE
-
Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation
NCT02594345 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases
NCT02171949 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells
NCT05017298 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
METHOD - Bone Marrow Derived Mononuclear Cells in Chronic Ischemic Disease
NCT01666132 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)
NCT03423732 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products
NCT02056613 ·Status: WITHDRAWN
-
Characterization of Exosomes Platelets-released
NCT06298682 ·Status: RECRUITING
-
Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells
NCT04313322 ·Status: UNKNOWN ·Phase: PHASE1
-
Regenerative Effects of Birth Material Derived Extracellular Vesicles
NCT06866184 ·Status: NOT_YET_RECRUITING
-
Stem Cell Collection
NCT00316069 ·Status: TERMINATED
-
hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury
NCT03386708 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars
NCT03181087 ·Status: WITHDRAWN ·Phase: PHASE1
-
Inactivation of Whole Blood With Mirasol
NCT01907906 ·Status: COMPLETED ·Phase: PHASE1
-
Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy
NCT02694562 ·Status: COMPLETED ·Phase: NA
-
Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury
NCT02687672 ·Status: UNKNOWN ·Phase: PHASE2
-
Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome
NCT05682560 ·Status: COMPLETED ·Phase: PHASE2
-
Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease
NCT03090672 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
NCT05520112 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia
NCT03913026 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cell Therapy in Chronic Limb Ischemia
NCT00533104 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia
NCT04255004 ·Status: COMPLETED ·Phase: NA